Viridian Therapeutics(VRDN.US)

Last Updated 19:00:00 ET
longbridge loading

How Investors May Respond To Viridian Therapeutics (VRDN) Debt Repayment And WuXi Manufacturing Pact

Simplywall·
US
VRDN
+1.30%
US
WXXWY
+2.33%
HK
02269
+3.81%
Simplywall·
US
VRDN
+1.30%
US
WXXWY
+2.33%
HK
02269
+3.81%

Viridien: Availability of the preparatory documents for the Combined General Meeting | CGG Stock News

StockTitan·
US
VRDN
+1.30%
StockTitan·
US
VRDN
+1.30%

Viridien: Information on the total number of voting rights and shares | CGG Stock News

StockTitan·
US
VRDN
+1.30%
StockTitan·
US
VRDN
+1.30%

Barclays Releases a Buy Rating on Viridien (0RI9)

Tip Ranks·
US
VRDN
+1.30%
Tip Ranks·
US
VRDN
+1.30%

Viridien (0RI9) Receives a Rating Update from a Top Analyst

Tip Ranks·
US
VRDN
+1.30%
Tip Ranks·
US
VRDN
+1.30%

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million | VRDN Stock News

StockTitan·
US
VRDN
+1.30%
US
BBH
-0.17%
US
IBB
+0.10%
StockTitan·
US
VRDN
+1.30%
US
BBH
-0.17%
US
IBB
+0.10%
© 2026 Longbridge｜Disclaimer